J
Jun Liang
Researcher at Peking Union Medical College
Publications - 107
Citations - 1635
Jun Liang is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Radiation therapy & Esophageal cancer. The author has an hindex of 16, co-authored 97 publications receiving 1140 citations.
Papers
More filters
Journal ArticleDOI
Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients
Zefen Xiao,Zong Yi Yang,Jun Liang,Yan Jun Miao,Mei Wang,Wei Bo Yin,Xian Zhi Gu,De Chao Zhang,Ru Gang Zhang,Liang Jun Wang +9 more
TL;DR: Postoperative prophylactic radiotherapy improved the 5-year survival rate in esophageal cancer patients with positive lymph node metastases and in patients with stage III disease compared with similar patients who did not receive radiation therapy.
Journal ArticleDOI
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial
Jun Liang,Nan Bi,S. Wu,Ming Chen,C. Lv,L. Zhao,A. Shi,Wei Jiang,Yaomin Xu,Zongmei Zhou,Wei Wang,Dongfu Chen,Zhouguang Hui,J. Lv,Hongxing Zhang,Qinfu Feng,Zefen Xiao,Xin Wang,Lipin Liu,Tao Zhang,Liping Du,Wei Chen,Yu Shyr,Weibo Yin,Jian Li,Jie He,Luhua Wang +26 more
TL;DR: EP might be superior to weekly PC in terms of OS in the setting of concurrent chemoradiation for unresectable stage III NSCLC.
Journal ArticleDOI
Effect of Postoperative Radiotherapy for Patients With pIIIA-N2 Non–Small Cell Lung Cancer After Complete Resection and Adjuvant Chemotherapy: The Phase 3 PORT-C Randomized Clinical Trial
Zhouguang Hui,Yu Men,Chen Hu,J. Kang,J. Kang,Xin Sun,Nan Bi,Zongmei Zhou,Jun Liang,Jima Lv,Qinfu Feng,Zefen Xiao,Dongfu Chen,Yan Wang,Junling Li,Jie Wang,Shugeng Gao,Luhua Wang,Jie He +18 more
TL;DR: The PORT-C randomized clinical trial was conducted in 394 patients with pIIIA-N2 non-small cell lung cancer (NSCLC) treated with complete resection and 4 cycles of platinum-based chemotherapy between January 2009 and December 2017.
Journal ArticleDOI
Primary small cell carcinoma of the esophagus.
TL;DR: Tumor stage, length of the primary lesion, and chemotherapy, but not surgery were independent prognostic factors in a multivariate analysis of SCEC and systemic therapy, based on chemotherapy with radiotherapy, is recommended.
Journal ArticleDOI
Postoperative Radiotherapy for Resected Pathological Stage IIIA–N2 Non-Small Cell Lung Cancer: A Retrospective Study of 221 Cases from a Single Institution
Honghai Dai,Zhouguang Hui,W. Ji,Jun Liang,Ji-ma Lü,Guangfei Ou,Zongmei Zhou,Qinfu Feng,Zefen Xiao,Dongfu Chen,Hongxing Zhang,Weibo Yin,Jie He,Luhua Wang +13 more
TL;DR: PORT can significantly improve the survival of patients with resected pathological stage IIIA-N2 NSCLC and a prospective randomized multicenter clinical trial is ongoing.